Search Results (897)

Background/Objectives: Alzheimer’s disease (AD) is the leading cause of dementia, which is an inevitable consequence of aging. Early detection of AD, or detection during the pre-AD stage, is beneficial, as it enables timely intervention to reduce modifiable risk factors, which may help prevent or delay the progression to dementia. On the one hand, plasma biomarkers have demonstrated great promise in predicting cognitive decline. On the other hand, in recent years, ocular imaging features, particularly the thickness of retinal layers measured by spectral-domain optical coherence tomography (SD-OCT), are emerging as possible non-invasive, non-contact surrogate markers for early detection and monitoring of neurodegeneration. This pilot study aims to identify retinal layer thickness changes across the entire retina linked to plasma AD biomarkers in cognitively healthy (CH) elderly individuals at risk for AD. Methods: Eleven CH individuals (20 eyes total) were classified in the pre-AD stage by plasma β-amyloid (Aβ)42/40 ratio < 0.10 and underwent SD-OCT. A deep-learning-derived automated algorithm was used to segment retinal layers on OCT (with manual correction when needed). Multiple layer thicknesses throughout the entire retina (including the inner retina, the outer retina, and the choroid) were measured in the inner ring (1–3 mm) and outer ring (3–6 mm) of the Early Treatment Diabetic Retinopathy Study (ETDRS). Relationships between retinal layers and plasma biomarkers were analyzed by ridge regression/bootstrapping. Results: Results showed that photoreceptor inner segment (PR-IS) thinning had the largest size effect with neurofilament light chain. Additional findings revealed thinning or thickening of the other retinal layers in association with increasing levels of glial fibrillary acidic protein and phosphorylated tau at threonine 181 and 217 (p-tau181 and p-tau217). Conclusions: This pilot study suggests that retinal layer-specific signatures exist, with PR-IS thinning as the largest effect, indicating neurodegeneration in pre-AD. Further research is needed to confirm the findings of this pilot study using larger longitudinal pre-AD cohorts and comparative analyses with healthy aging adults. Full article

Lensless microscopy is a well-established imaging approach that replaces traditional lenses with phase modulators, enabling compact, low-cost, and computationally driven analysis of biological samples. In this work, we show how ray tracing simulations can be used to optimize lensless imaging systems for automated classification, particularly for detecting red blood cell (RBC) disease. Rather than improving the machine learning classification algorithm, our focus is on refining optical parameters such as element spacing and modulator type to maximize classification performance. We modeled a lensless microscope in Zemax OpticStudio (ray tracing) and compared the results against Fourier optics simulations. Despite not explicitly modeling diffraction, ray tracing produced classification results largely consistent with wave optics simulations, confirming its effectiveness for parameter optimization in lensless imaging setups used for classification tasks. Furthermore, to show the flexibility of the ray tracing model, we introduced a microlens array (MLA) as the phase modulator and performed the classification task on the generated patterns. These results establish ray tracing as an efficient tool for the optical design of lensless microscopy systems intended for machine learning based biomedical applications. The developed lensless microscopy model enables the generation of datasets for training neural networks. Full article

Background/Objectives: The vaginal microbiota constitutes a highly dynamic microbial ecosystem shaped by the distinct mucosal, hormonal, and immunological environment of the female genital tract. Accumulating evidence suggests that shifts in cervical microbial composition and function may influence host–microbe interactions and contribute to gynecological disease risk. Within this framework, the present study aimed to perform an in-depth genomic characterization of the cervical microbiota in a well-defined cohort of Greek women. The primary objective was to explore the functional microbial landscape by identifying dominant bacterial taxa, taxon-specific signatures, and potential microbial pathways implicated in cervical epithelial homeostasis, immune modulation, and disease susceptibility. Methods: Microbial genomic DNA was isolated from 60 cervical samples using the Magcore Bacterial Automated Kit and analyzed through full-length 16S rRNA gene sequencing using the Nanopore MinION™ platform, allowing high-resolution taxonomic assignment and enhanced functional inference. In parallel, cervical samples were screened for 14 HPV genotypes using a real-time PCR-based assay. Results: The cervical microbial communities were dominated by Lactobacillus iners, Lactobacillus crispatus, and Aerococcus christensenii, collectively representing over 75% of total microbial abundance and suggesting a functionally protective microbiota profile. A diverse set of low-abundance taxa—including Stenotrophomonas maltophilia, Stenotrophomonas pavanii, Acinetobacter septicus, Rhizobium spp. (Rhizobium rhizogenes, Rhizobium tropici, Rhizobium jaguaris), Prevotella amnii, Prevotella disiens, Brevibacterium casei, Fannyhessea vaginae, and Gemelliphila asaccharolytica—was also detected, potentially reflecting niche-specific metabolic functions or environmental microbial inputs. No HPV genotypes were detected in any of the cervical samples. Conclusions: This genomic profiling study underscores the functional dominance of Lactobacillus spp. within the cervical microbiota and highlights the contribution of low-abundance taxa that may participate in metabolic cross-feeding, immune signaling, or epithelial barrier modulation. Future large-scale, multi-omics studies integrating metagenomics and host transcriptomic data are warranted to validate microbial functional signatures as biomarkers or therapeutic targets for cervical health optimization. Full article

Background/Objectives: Cardiovascular diseases are the leading cause of mortality worldwide according to the World Health Organization (WHO), highlighting the need for accessible tools for early detection. Automated classification systems based on signal processing and machine learning offer a non-invasive alternative to support clinical diagnosis. Methods: This study implements and evaluates machine learning models for distinguishing normal and abnormal heart sounds using a hybrid feature extraction approach. Recordings labeled as normal, murmur, and extrasystolic were obtained from the PASCAL dataset and subsequently binarized into two classes. Multiple numerical datasets were generated through statistical features derived from Mel-Frequency Cepstral Coefficients (MFCCs) and Daubechies wavelet analysis. Each dataset was standardized and used to train four classifiers: support vector machines, logistic regression, random forests, and decision trees. Results: Model performance was assessed using accuracy, precision, recall, specificity, F1-score, and area under curve. All classifiers achieved notable results; however, the support vector machine model trained with 26 MFCCs and Daubechies-4 wavelet coefficients obtained the best performance. Conclusions: These findings demonstrate that the proposed hybrid MFCC–Wavelet framework provides competitive diagnostic accuracy and represents a lightweight, interpretable, and computationally efficient solution for computer-aided auscultation and early cardiovascular screening. Full article

Background/Objectives: Differential scanning calorimetry (DSC) analysis of blood plasma, also known as thermal liquid biopsy (TLB), is a promising approach for disease detection and monitoring; however, its wider adoption in clinical settings has been hindered by labor-intensive data processing workflows, particularly baseline correction. Methods: We developed and tested two automated algorithms to address critical bottlenecks in TLB analysis: (1) a baseline-correction algorithm utilizing rolling-variance analysis for endpoint detection, and (2) a signal-detection algorithm that applies auto-regressive integrated moving average (ARIMA)-based stationarity testing to determine whether a profile contains interpretable thermal features. Both algorithms are implemented in ThermogramForge, an open-source R Shiny web application providing an end-to-end workflow for data upload, processing, and report generation. Results: The baseline-correction algorithm demonstrated excellent performance on plasma TLB data (characterized by high heat capacity), matching the quality of rigorous manual processing. However, its performance was less robust for low signal biofluids, such as urine, where weak thermal transitions reduce the reliability of baseline estimation. To address this, a complementary signal-detection algorithm was developed to screen for TLB profiles with discernable thermal transitions prior to baseline correction, enabling users to exclude non-informative data. The signal-detection algorithm achieved near-perfect classification accuracy for TLB profiles with well-defined thermal transitions and maintained a low false-positive rate of 3.1% for true noise profiles, with expected lower performance for borderline cases. The interactive review interface in ThermogramForge further supports quality control and expert refinement. Conclusions: The automated baseline-correction and signal-detection algorithms, together with their web-based implementation, substantially reduce analysis time while maintaining quality, supporting more efficient and reproducible TLB research. Full article

Microfluidic cell culture systems and organ-on-a-chip platforms provide powerful tools for modeling physiological processes, disease progression, and drug responses under controlled microenvironmental conditions. These technologies rely on diverse cell culture methodologies, including 2D and 3D culture formats, spheroids, scaffold-based systems, hydrogels, and organoid models, to recapitulate tissue-level functions and generate rich, multiparametric datasets through high-resolution imaging, integrated sensors, and biochemical assays. The heterogeneity and volume of these data introduce substantial challenges in pre-processing, feature extraction, multimodal integration, and biological interpretation. Artificial intelligence (AI), particularly machine learning and deep learning, offers solutions to these analytical bottlenecks by enabling automated phenotyping, predictive modeling, and real-time control of microfluidic environments. Recent advances also highlight the importance of technical frameworks such as dimensionality reduction, explainable feature selection, spectral pre-processing, lightweight on-chip inference models, and privacy-preserving approaches that support robust and deployable AI–microfluidic workflows. AI-enabled microfluidic and organ-on-a-chip systems now span a broad application spectrum, including cancer biology, drug screening, toxicity testing, microbial and environmental monitoring, pathogen detection, angiogenesis studies, nerve-on-a-chip models, and exosome-based diagnostics. These platforms also hold increasing potential for precision medicine, where AI can support individualized therapeutic prediction using patient-derived cells and organoids. As the field moves toward more interpretable and autonomous systems, explainable AI will be essential for ensuring transparency, regulatory acceptance, and biological insight. Recent AI-enabled applications in cancer modeling, drug screening, etc., highlight how deep learning can enable precise detection of phenotypic shifts, classify therapeutic responses with high accuracy, and support closed-loop regulation of microfluidic environments. These studies demonstrate that AI can transform microfluidic systems from static culture platforms into adaptive, data-driven experimental tools capable of enhancing assay reproducibility, accelerating drug discovery, and supporting personalized therapeutic decision-making. This narrative review synthesizes current progress, technical challenges, and future opportunities at the intersection of AI, microfluidic cell culture platforms, and advanced organ-on-a-chip systems, highlighting their emerging role in precision health and next-generation biomedical research. Full article

Background/Objectives: Different oxylipin subtypes have unique biological properties, requiring effective analytical protocols. However, establishing a complete pathway detection protocol for comprehensive oxylipin analysis is challenging. This study aimed to evaluate the adaptability and specificity of oxylipin subtypes under different extraction schemes and to develop a robust analytical platform for clinical biomarker investigation. Methods: We revealed the adaptability and specificity of oxylipin subtypes based on different single-step extraction schemes. A high-throughput quantitative automated solid-phase extraction coupled with a liquid chromatography–tandem mass spectrometry (aSPE–LC–MS/MS) analytical platform was established for a broad panel of complex oxylipins. The method was applied to serum samples of patients with coronary heart disease (CHD). Results: Our results verified that oxo-oxylipins, resolvin, and eicosanoids showed the best extraction efficiency under SPE protocol. Most hydroxy-oxylipins, dihydroxy-oxylipins, and HOTrEs are suitable for methanol protocol, HDHA for acetonitrile protocol, and epoxy-oxylipins for the methyl tert-butyl ether protocol, while medium-chain HETE is suitable for ethyl acetate protocol. Importantly, a novel sensitive fast method with wide coverage by the aSPE–LC–MS/MS analytical platform with satisfying sensitivity, accuracy and precision, extraction efficiency, low matrix effect, and linear calibration curves was obtained. Furthermore, we have successfully applied this method and found that 5-HETE, 11-HETE, and 15-HETE can serve as integrated biomarkers for patients with CHD, with high diagnostic performance. Conclusions: The study provides the best protocol for the clinically targeted detection of oxylipins and provides an important means for studying biomarkers of diseases. Full article

Background/Objectives: Demodex mites are a common yet underdiagnosed cause of ocular surface diseases, including blepharitis and meibomian gland dysfunction (MGD). Traditional diagnosis via microscopic examination is labor-intensive and time-consuming. This study aimed to develop a deep learning-based system for the automated detection and quantification of Demodex mites from microscopic eyelash images. Methods: We collected 1610 microscopic images of eyelashes from patients clinically suspected to have ocular demodicosis. After quality screening, 665 images with visible Demodex features were annotated and processed. Two deep learning models, YOLOv11 and RT-DETR, were trained and evaluated using standard metrics. Grad-CAM visualization was applied to confirm model attention and feature localization. Results: Both YOLO and RT-DETR models were able to detect Demodex mites in our microscopic images. The YOLOv11 boxing model revealed an average precision of 0.9441, sensitivity of 0.9478, and F1-score of 0.9459 in our detection system, while the RT-DETR model showed an average precision of 0.7513, sensitivity of 0.9389, and F1-score of 0.8322. Moreover, Grad-CAM visualization confirmed the models’ focus on relevant mite features. Quantitative analysis enabled consistent mite counting across overlapping regions, with a confidence level of 0.4–0.8, confirming stable enumeration performance. Conclusions: The proposed artificial intelligence (AI)-based detection system demonstrates strong potential for assisting ophthalmologists in diagnosing ocular demodicosis efficiently and accurately, reducing reliance on manual microscopy and enabling faster clinical decision making. Full article

Corneal diseases are a leading cause of blindness worldwide, although their early detection remains challenging due to subtle clinical presentations. Recent advances in artificial intelligence (AI) have shown promising diagnostic performance for anterior segment disorders. This narrative review summarizes current applications of AI in the detection of corneal conditions—including keratoconus (KC), dry eye disease (DED), infectious keratitis (IK), pterygium, Fuchs endothelial corneal dystrophy (FECD), and corneal transplantation. Many AI models report high accuracy on test datasets, comparable to, and in some studies exceeding, that of junior ophthalmologists. In addition to detection, AI systems can automate image labeling and support education and patient home monitoring. These findings highlight the potential of AI to improve early management and standardized classification of corneal diseases, supporting clinical practice and patient self-care. Full article

Conjunctival inflammation assessment is fundamental for diagnosing and monitoring various ocular surface diseases. This review summarizes grading scales available for conjunctival inflammation, discussing both subjective and objective methodologies. Widely used clinical grading systems include slit-lamp findings classification scale, Mandell scale for conjunctival injection, McMonnies and Champman-Davies scale, CCLRU (Cornea and Contact Lens Research Unit) scale, Efron scale, and VBR (validated bulbar redness) scale. They provide standardized frameworks for assessing conjunctival hyperemia and inflammation severity. However, these subjective methods are limited by inter-observer variability and lack of precision in detecting subtle changes. Recent technological advances have introduced objective digital imaging systems and automated algorithms that may offer improved reproducibility and sensitivity. Novel approaches include the integration of artificial intelligence for automated assessment. The validation of these scales across diverse patient populations has demonstrated varying degrees of reliability and clinical utility. Current evidence suggests that while traditional subjective scales remain clinically relevant, objective measurement systems provide superior repeatability and may better serve research applications requiring precise quantification of inflammatory changes. This review summarizes current knowledge regarding conjunctival inflammation grading methodologies and provides insights into novel developments in the field. Full article

Unobserved fruit crop illnesses are a major threat to agricultural productivity worldwide and frequently cause farmers to suffer large financial losses. Manual field inspection-based disease detection techniques are time-consuming, unreliable, and unsuitable for extensive monitoring. Deep learning approaches, in particular convolutional neural networks, have shown promise for automated plant disease identification, although they still face significant obstacles. These include poor generalization across complicated visual backdrops, limited resilience to different illness sizes, and high processing needs that make deployment on resource-constrained edge devices difficult. We suggest a Hybrid Multi-Scale Neural Network (HMCT-AF with GSAF) architecture for precise and effective fruit crop disease identification in order to overcome these drawbacks. In order to extract long-range dependencies, HMCT-AF with GSAF combines a Vision Transformer-based structural branch with multi-scale convolutional branches to capture both high-level contextual patterns and fine-grained local information. These disparate features are adaptively combined using a novel HMCT-AF with a GSAF module, which enhances model interpretability and classification performance. We conduct evaluations on both PlantVillage (controlled environment) and CLD (real-world in-field conditions), observing consistent performance gains that indicate strong resilience to natural lighting variations and background complexity. With an accuracy of up to 93.79%, HMCT-AF with GSAF outperforms vanilla Transformer models, EfficientNet, and traditional CNNs. These findings demonstrate how well the model captures scale-variant disease symptoms and how it may be used in real-time agricultural applications using hardware that is compatible with the edge. According to our research, HMCT-AF with GSAF presents a viable basis for intelligent, scalable plant disease monitoring systems in contemporary precision farming. Full article

Technology-driven agriculture, or precision agriculture (PA), is indispensable in the contemporary world due to its advantages and the availability of technological innovations. Particularly, early disease detection in agricultural crops helps the farming community ensure crop health, reduce expenditure, and increase crop yield. Governments have mainly used current systems for agricultural statistics and strategic decision-making, but there is still a critical need for farmers to have access to cost-effective, user-friendly solutions that can be used by them regardless of their educational level. In this study, we used four apple leaf diseases (leaf spot, mosaic, rust and brown spot) from the PlantVillage dataset to develop an Automated Agricultural Crop Disease Identification System (AACDIS), a deep learning framework for identifying and categorizing crop diseases. This framework makes use of deep convolutional neural networks (CNNs) and includes three CNN models created specifically for this application. AACDIS achieves significant performance improvements by combining cascade inception and drawing inspiration from the well-known AlexNet design, making it a potent tool for managing agricultural diseases. AACDIS also has Region of Interest (ROI) awareness, a crucial component that improves the efficiency and precision of illness identification. This feature guarantees that the system can quickly and accurately identify illness-related areas inside images, enabling faster and more accurate disease diagnosis. Experimental findings show a test accuracy of 99.491%, which is better than many state-of-the-art deep learning models. This empirical study reveals the potential benefits of the proposed system for early identification of diseases. This research triggers further investigation to realize full-fledged precision agriculture and smart agriculture. Full article

Background/Objectives: This review evaluates the expanding contributions of artificial intelligence (AI) across biomedicine, focusing on cancer therapy and nanomedicine, cardiology and medical imaging, neurodegenerative disorders, and liver disease. Core AI concepts (machine learning, deep learning, artificial neural networks, model training/validation, and explainability) are introduced to frame application domains. Methods: A systematic search of major biomedical databases (2010–2025) identified English-language original studies on AI in these four areas; 203 articles meeting PRISMA 2020 criteria were included in a qualitative synthesis. Results: In oncology and nanomedicine, AI-driven methods expedite nanocarrier design, predict biodistribution and treatment response, and enable nanoparticle-enhanced monitoring. In cardiology, algorithms enhance ECG interpretation, coronary calcium scoring, automated image segmentation, and noninvasive FFR estimation. For neurological disease, multimodal AI models integrate imaging and biomarker data to improve early detection and patient stratification. In hepatology, AI supports digital histopathology, augments intraoperative robotics, and refines transplant wait-list prioritization. Common obstacles are highlighted, including data heterogeneity, lack of standardized acquisition protocols, model transparency, and the scarcity of prospective multicenter validation. Conclusions: AI is emerging as a practical enabler across these biomedical fields, but its safe and equitable use requires harmonized data, rigorous multicentre validation, and more transparent models to ensure clinical benefit while minimizing bias. Full article

Plant diseases pose a significant threat to global food security, affecting crop yield, quality, and overall agricultural productivity. Traditionally, diagnosing plant diseases has relied on time-consuming visual inspections by experts, which can often lead to errors. Machine learning (ML) and artificial intelligence (AI), particularly Vision Transformers (ViTs), and Convolutional Neural Networks, offer a faster, automated alternative for identifying plant diseases through leaf image analysis. However, these models are often criticized for their “black box” nature, limiting trust in their predictions due to a lack of transparency. Our findings show that incorporating Explainable AI (XAI) techniques, such as Grad-CAM, Integrated Gradients, and LIME, significantly improves model interpretability, making it easier for practitioners to identify the underlying symptoms of plant diseases. This study not only contributes to the field of plant disease detection but also offers a novel perspective on improving AI transparency in real-world agricultural applications through the use of XAI techniques. With training accuracies of 100.00% for ViT, 96.88% for EfficientNetB7, 93.75% for EfficientNetB0, and 87.50% for ResNet50, and corresponding validation accuracies of 96.39% for ViT, 86.98% for EfficientNetB7, and 82.00% for EfficientNetB0, our proposed models outperform earlier research on the same dataset. This demonstrates a notable improvement in model performance while maintaining transparency and trustworthiness through interpretable and reliable decision-making. Full article

While magnetic resonance imaging (MRI) is effective for detecting early-stage osteonecrosis of the femoral head (ONFH), it is often expensive and less accessible; conversely, radiography is more widely accessible but has limited sensitivity for early-stage diagnosis. We developed a deep learning approach using radiographic images to effectively classify ONFH stages, providing a more accessible method for early diagnosis and disease stage differentiation. The dataset consisted of 909 hip radiographs, yielding 1818 femoral head images (grade 0:1495; grade 1:80; grade 2:114; grade 3:93; grade 4:36). A U-Net model was used to segment the femoral heads, achieving a Dice similarity coefficient (DSC) of 0.977 on the test set, allowing precise localization of the region of interest. A variational autoencoder (VAE) was then trained using 1270 grade-0 images for training and 112 for validation to construct a normative latent distribution representing healthy femoral heads. When ONFH data from all grades were projected into the latent space, significant differences in Mahalanobis distance distributions were observed across most ONFH stages. No significant difference was found between grades 0 and 1 (p = 0.06), consistent with known radiographic subtlety. However, grades 2–4 showed significant deviation from grade 0, and significant differences were also observed among mid- and late-stage grades. These findings demonstrate that the proposed method effectively separates healthy and diseased femoral heads and captures gradewise structural progression within the latent space. This radiograph-based normative modeling approach offers an accessible alternative to MRI for ONFH stage differentiation, particularly in resource-limited clinical environments. Although early-stage differentiation remains challenging, the results highlight the potential of radiograph-based deep learning systems to improve diagnostic efficiency and support future automated ONFH staging workflows. Full article